Biofourmis Funding & Investors
Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics. The company discovers, develops, and delivers clinically validated software-based therapeutics to enable better outcomes for patients. These solutions include advanced tools for clinicians to deliver personalized care and cost-effective solutions for payers. Biofourmis was founded in 2015 and headquartered in Boston, Massachusetts.
https://biofourmis.com/Total Amount Raised:
Biofourmis Funding Rounds
Series D
$300,000,000
Series D Investors
Openspace VenturesCVS HealthEDBIGeneral AtlanticSeries C
$100,000,000
Series C Investors
Openspace VenturesSoftBank Investment AdvisersEDBICapikris FoundationMMV Europe & Asia-PacificSequoia CapitalSeries B
$35,000,000
Series B Investors
Openspace VenturesPeak XV PartnersEDBIAviva VenturesMMV Europe & Asia-PacificSGInnovateJiankeSeries A
$2,000,000
Series A Investors
Aviva VenturesSGInnovateSeries A
$5,000,000
Series A Investors
Openspace VenturesAviva VenturesSeed
$500,000
Seed Investors
SpesNetAngel
$1,000,000
Angel Investors
Eden Strategy InstituteSpesNetSeries D
$20,000,000
Series D Investors
Intel CapitalAngel
100,000 SGD
Angel Investors
Eden Strategy Institute
Funding info provided by Diffbot.